News

It happens all the time. A man gets older, but he doesn't think he needs to be checked for prostate cancer. Even if his father or grandfather had prostate cancer, he feels fine, and does not see the need for yearly physical exams. However, the reality is that 1 in 7 American men will be diagnosed with prostate cancer at some point in his lifetime.

A pilot program initiated by UnitedHealthcare involving 5 oncology groups that focused on best treatment practices and health outcomes, rather than the number of drugs that oncologists prescribe, resulted in a 34% reduction in medical costs.

Researchers at the National Cancer Institute (NCI) have found that a negative HPV screening test is better at evaluating cervical cancer risk than a negative Pap test.

FORCE has collaborated with researchers at the University of South Florida and the Michigan Department of Community Health to form the ABOUT Patient-Powered Research Network

Clinical practice guidelines show no agents prevent this side effect.

Cardiac events associated with trastuzumab (Herceptin) are mostly reversible and outweighed by significant extensions in overall survival (OS) and progression-free survival (PFS) for patients with HER2-positive breast cancer

A gel formulation of tamoxifen is equally as effective with fewer side effects when compared with oral tamoxifen in women with ductal carcinoma in situ

This college admissions essay, penned by 17-year-old Samantha Stephens, offers a powerful and poignant reminder of the impact a cancer diagnosis can have on a patient's family and caregivers.

For patients receiving treatment for oral and head and neck cancer, maintaining adequate nutrition is an ongoing challenge.

The risk for pancreatic cancer dramatically decreases the longer a person takes low-dose aspirin

Meta-analysis finds more research is needed.

Tim Turnham, executive director, Melanoma Research Foundation, provides an overview of some of the services offered by the Melanoma Research Foundation.

Researchers from the nursing school at Case Western Reserve University have found caregivers of terminal cancer patients reported a high degree of satisfaction when they had a team available to them through difficult decisions and end-of-life treatment for their loved one.

Spending all day sitting on the couch to binge watch your favorite television show not only isn't great for your waistline, recent research suggests it could increase your risk for cancer.

Androgen-deprivation therapy (ADT) is a mainstay of treatment for prostate cancer in a number of settings, so managing its side effects is becoming increasingly important for urologists and oncology practitioners in collaboration with primary care physicians.

Everything we know and will learn in the future about hereditary cancer risks, screening, and treatment comes from years of scientific research and the direct participation of thousands of volunteers.

An approach using heat to alleviate the pain commonly associated with bone metastases has proven to be safe and effective in a multicenter phase III clinical trial, yielding a 64% response rate based on self-reported pain scores among patients receiving the noninvasive intervention.

Faculty from nursing education innovator will contribute unique perspective to OncLive's ongoing efforts to provide practical news and information for oncology professionals.

Data on electronic cigarette, or e-cigarettes, suggests that sales are up and it's predicted that e-cigarette sales will exceed cigarette sales in the next decade.

People infected with HIV who have also developed cancer are two to four times more likely to not receive treatment for their cancer compared to uninfected cancer patients,

Two recently published clinical studies demonstrated a strong association between higher levels of vitamin D and improved outcomes among patients with various cancers.

With the cost of cancer care ever rising, a team of cancer specialists at the University of Chicago has developed a tool to help measure a patient's risk for and ability to tolerate financial stress.

The results of two phase III trials reported at the 2014 MASCC/ISOO International Symposium on Supportive Care in Cancer have found that enobosarm, a first-in-class, nonsteroidal, oral selective androgen receptor modulator (SARM), led to an increase in lean body mass (LBM) compared with a decline in LBM observed with placebo for patients with non-small cell lung cancer (NSCLC).

The Prostate Cancer Foundation (PCF) is the world's leading philanthropic organization funding and accelerating prostate cancer research.

Adding the NK-1 receptor antagonist aprepitant to standard prophylaxis for chemotherapy-induced nausea and vomiting (CINV) yielded significant benefits for the prevention of CINV in children

A treatment intended to control chemotherapy-induced nausea and vomiting (CINV) that combines netupitant and palonosetron (NEPA) in a single capsule resulted in improved complete response rates (from 0 to 120 hours) when compared with oral palonosetron alone, according to research presented at the 2014 MASCC/ISOO International Symposium on Supportive Care in Cancer.

"AMEN" mnemonic may assist in sustaining hope.

The FDA has issued a drug safety communication regarding the risk of intoxication with the intravenous ethanol-containing chemotherapy docetaxel. The drug is marketed as generic docetaxel and under the brand names Taxotere, Docefrez, and Docetaxel Injection.